196 related articles for article (PubMed ID: 31956259)
21. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
[TBL] [Abstract][Full Text] [Related]
22. Extract from Phyllanthus urinaria L. inhibits hepatitis B virus replication and expression in hepatitis B virus transfection model in vitro.
Wu Y; Lu Y; Li SY; Song YH; Hao Y; Wang Q
Chin J Integr Med; 2015 Dec; 21(12):938-43. PubMed ID: 25869593
[TBL] [Abstract][Full Text] [Related]
23. Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds.
Gong PY; Yuan ZX; Gu J; Tan R; Li JC; Ren Y; Hu S
Molecules; 2016 Dec; 22(1):. PubMed ID: 28035986
[TBL] [Abstract][Full Text] [Related]
24. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
Zhao G; Yin Z; Dong J
J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
[TBL] [Abstract][Full Text] [Related]
25. Three new secoiridoids, swermacrolactones A-C and anti-hepatitis B virus activity from Swertia macrosperma.
Wang HL; Geng CA; Ma YB; Zhang XM; Chen JJ
Fitoterapia; 2013 Sep; 89():183-7. PubMed ID: 23756190
[TBL] [Abstract][Full Text] [Related]
26. Chemical constituents of Swertia yunnanensis and their anti-hepatitis B virus activity.
Cao TW; Geng CA; Jiang FQ; Ma YB; He K; Zhou NJ; Zhang XM; Zhou J; Chen JJ
Fitoterapia; 2013 Sep; 89():175-82. PubMed ID: 23747320
[TBL] [Abstract][Full Text] [Related]
27. Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes.
Geng CA; Yang TH; Huang XY; Yang J; Ma YB; Li TZ; Zhang XM; Chen JJ
J Ethnopharmacol; 2018 Oct; 224():283-289. PubMed ID: 29890315
[TBL] [Abstract][Full Text] [Related]
28. Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells.
Aoki-Utsubo C; Indrasetiawan P; Fukano K; Muramatsu M; Artanti N; Hanafi M; Hotta H; Kameoka M
Microbiol Immunol; 2023 Jun; 67(6):281-292. PubMed ID: 36929353
[TBL] [Abstract][Full Text] [Related]
29. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
[TBL] [Abstract][Full Text] [Related]
30. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
31. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells.
Cui X; Inagaki Y; Xu H; Wang D; Qi F; Kokudo N; Fang D; Tang W
Biol Pharm Bull; 2010; 33(10):1728-32. PubMed ID: 20930383
[TBL] [Abstract][Full Text] [Related]
32. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of a novel thiazolidinedione derivative on hepatitis B virus entry.
Tanaka T; Okuyama-Dobashi K; Motohashi R; Yokoe H; Takahashi K; Wiriyasermkul P; Kasai H; Yamashita A; Maekawa S; Enomoto N; Ryo A; Nagamori S; Tsubuki M; Moriishi K
Antiviral Res; 2021 Oct; 194():105165. PubMed ID: 34419484
[TBL] [Abstract][Full Text] [Related]
35. A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro.
Zeng Z; Zhang Q; Hong W; Xie Y; Liu Y; Li W; Wu Y; Cao Z
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128943
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hepatitis B virus by an aqueous extract of Agrimonia eupatoria L.
Kwon DH; Kwon HY; Kim HJ; Chang EJ; Kim MB; Yoon SK; Song EY; Yoon DY; Lee YH; Choi IS; Choi YK
Phytother Res; 2005 Apr; 19(4):355-8. PubMed ID: 16041735
[TBL] [Abstract][Full Text] [Related]
37. Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line.
Ogura N; Ogawa K; Watashi K; Ito T; Wakita T
Biochem Biophys Res Commun; 2018 Mar; 498(1):64-71. PubMed ID: 29481805
[TBL] [Abstract][Full Text] [Related]
38. Anti-HBV activities of Streblus asper and constituents of its roots.
Chen H; Li J; Wu Q; Niu XT; Tang MT; Guan XL; Li J; Yang RY; Deng SP; Su XJ
Fitoterapia; 2012 Jun; 83(4):643-9. PubMed ID: 22305944
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo anti-hepatitis B virus activities of the lignan nirtetralin B isolated from Phyllanthus niruri L.
Liu S; Wei W; Li Y; Lin X; Shi K; Cao X; Zhou M
J Ethnopharmacol; 2014 Nov; 157():62-8. PubMed ID: 25260580
[TBL] [Abstract][Full Text] [Related]
40. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
